CLDX
Celldex Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.33 / 10
Netural
Corporate fundamentals rate at 5.3/10, indicating a mixed outlook. Beneficial aspects include a solid interest-coverage ratio (15.48%) and positive Asset-MV, while challenges arise from negative revenue growth (YoY -75.6%) and operating revenue decline. Overall, the company's financial health is average, warranting cautious optimism.
Analysis Checks(6/10)
Revenue-MV
Value-0.26
Score1/3
Weight10.90%
1M Return4.24%
Value-0.26
Score1/3
Weight10.90%
1M Return4.24%
Days sales outstanding
Value74.89
Score0/3
Weight-9.59%
1M Return-5.18%
Value74.89
Score0/3
Weight-9.59%
1M Return-5.18%
Net income-Revenue
Value-0.17
Score2/3
Weight21.68%
1M Return8.45%
Value-0.17
Score2/3
Weight21.68%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-2.17%
1M Return-1.11%
Value15.48
Score2/3
Weight-2.17%
1M Return-1.11%
Asset-MV
Value-0.50
Score2/3
Weight27.92%
1M Return10.15%
Value-0.50
Score2/3
Weight27.92%
1M Return10.15%
Total operating revenue (YoY growth rate %)
Value-75.64
Score0/3
Weight-10.04%
1M Return-6.11%
Value-75.64
Score0/3
Weight-10.04%
1M Return-6.11%
Profit-MV
Value0.46
Score2/3
Weight21.65%
1M Return8.45%
Value0.46
Score2/3
Weight21.65%
1M Return8.45%
PB-ROE
Value1.60
Score2/3
Weight27.00%
1M Return9.14%
Value1.60
Score2/3
Weight27.00%
1M Return9.14%
Operating revenue (YoY growth rate %)
Value-75.64
Score0/3
Weight-8.64%
1M Return-5.06%
Value-75.64
Score0/3
Weight-8.64%
1M Return-5.06%
Cash-MV
Value-0.07
Score2/3
Weight21.29%
1M Return8.41%
Value-0.07
Score2/3
Weight21.29%
1M Return8.41%
Revenue-MV
Value-0.26
Score1/3
Weight10.90%
1M Return4.24%
Value-0.26
Score1/3
Weight10.90%
1M Return4.24%
Total operating revenue (YoY growth rate %)
Value-75.64
Score0/3
Weight-10.04%
1M Return-6.11%
Value-75.64
Score0/3
Weight-10.04%
1M Return-6.11%
Days sales outstanding
Value74.89
Score0/3
Weight-9.59%
1M Return-5.18%
Value74.89
Score0/3
Weight-9.59%
1M Return-5.18%
Profit-MV
Value0.46
Score2/3
Weight21.65%
1M Return8.45%
Value0.46
Score2/3
Weight21.65%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight21.68%
1M Return8.45%
Value-0.17
Score2/3
Weight21.68%
1M Return8.45%
PB-ROE
Value1.60
Score2/3
Weight27.00%
1M Return9.14%
Value1.60
Score2/3
Weight27.00%
1M Return9.14%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-2.17%
1M Return-1.11%
Value15.48
Score2/3
Weight-2.17%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value-75.64
Score0/3
Weight-8.64%
1M Return-5.06%
Value-75.64
Score0/3
Weight-8.64%
1M Return-5.06%
Asset-MV
Value-0.50
Score2/3
Weight27.92%
1M Return10.15%
Value-0.50
Score2/3
Weight27.92%
1M Return10.15%
Cash-MV
Value-0.07
Score2/3
Weight21.29%
1M Return8.41%
Value-0.07
Score2/3
Weight21.29%
1M Return8.41%
Is CLDX fundamentally strong?
- CLDX scores 5.33/10 on fundamentals and holds a Fair valuation at present. Backed by its -26.38% ROE, -8639.17% net margin, -7.90 P/E ratio, 2.64 P/B ratio, and -31.01% earnings growth, these metrics solidify its Netural investment rating.
